Pediatrix Medical Group, Inc. (MD) Q3 2026 earnings results
Pediatrix Medical Group, Inc. (MD) reported Q3 2026 results on Oct 29, 2026, 6:50:15 AM ET: adjusted EPS $0.72 vs. $0.65 expected (beat by 10.8%); revenue $501.37M vs. $498.18M expected (beat by 0.6%). Outlook: Pediatrix anticipates that its full year 2026 outlook for Adjusted EBITDA will be in a range of $290 million to $300 million.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (adjusted, diluted) | $0.72 | $0.65 | Beat by 10.8% |
| Revenue | $501.37M | $498.18M | Beat by 0.6% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Oct 29, 2026, 6:50:15 AM ET. Nexqual published them 35 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 1.7% from $492.88M.
Stock reaction
The results came out before the market opened. MD closed at $29.18 on October 29, 2026, up 0.9% from its $28.91 close on October 28, 2026 before the results.
Questions and answers
Did Pediatrix Medical Group, Inc. beat earnings expectations?
Yes. Pediatrix Medical Group, Inc. reported adjusted EPS of $0.72 against an average analyst estimate of $0.65 (beat by 10.8%), and revenue of $501.37M against $498.18M expected (beat by 0.6%).
What were Pediatrix Medical Group, Inc.'s Q3 2026 earnings and revenue?
adjusted diluted EPS of $0.72 and revenue of $501.37M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 1.7% from $492.88M.
When did Pediatrix Medical Group, Inc. report Q3 2026 earnings?
Oct 29, 2026, 6:50:15 AM ET, in an SEC 8-K filing (Item 2.02).
How did MD stock react to the earnings?
The results came out before the market opened. MD closed at $29.18 on October 29, 2026, up 0.9% from its $28.91 close on October 28, 2026 before the results.
What did Pediatrix Medical Group, Inc. say about its outlook?
Pediatrix anticipates that its full year 2026 outlook for Adjusted EBITDA will be in a range of $290 million to $300 million.
More on MD
MD stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings October 29, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built October 29, 2026 at 23:07 UTC. Not investment advice.
Data source: Nexqual. Last updated: October 29, 2026 at 23:07 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt